IntelGenx Technologies Corp. (IGXT), a drug delivery company, is another of Cleland's holdings. The company develops systems to administer drugs to patients more simply or to make the drugs more effective.
"It's a very low risk" approach because the company is using already approved drugs, the fund manager said.